Log in Sign up
1 Matching Annotations
  1. Last 7 days
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease
    1
    1. ClingenBaseline 24 Oct 2026
      in Baseline Annotations
      LOPD-10

      CaseLOPD-10: 2 weeks diagnosis

      HPOsFreeText: GAA activity 2.5 (nmol · h−1 · mg−1), Mean percentage of normal 3.6%

      GenotypingMethod: Newborn Screening Panels


      Variant1: NM_000152.4:c.517_519del (p.M173del)

      CAID: CA891862611 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3:c.517_519del

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.710C>T (p.Ala237Val)

      ClinVar: 4035 https://www.ncbi.nlm.nih.gov/clinvar/variation/4035/

      gnomAD: South Asian 1.307e-4, Overall 1.992e-5 http://gnomad.broadinstitute.org/variant/17-78081373-C-T


      CaseAddInfo: Late Onset Pompe Disease

      Individual Variant CaseInfo GenotypingMethod ClinVarID:4035 CA891862611 inferred_gene_hgnc:4065 inferred_gene_source:CAID GAA variant
    Visit annotations in context

    Tags

    • inferred_gene_hgnc:4065
    • CA891862611
    • inferred_gene_source:CAID
    • ClinVarID:4035
    • CaseInfo
    • Variant
    • GenotypingMethod
    • Individual
    • GAA variant

    Annotators

    • ClingenBaseline

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC5413112/
Share:
Group. Only group members will be able to view this annotation.
Only me. No one else will be able to view this annotation.
Hypothes.is
  • About
  • Blog
  • Bioscience
  • Education
  • Jobs
  • Help
  • Contact
  • Terms of Service
  • Privacy Policy